ARTICLE
|
doi:10.20944/preprints202312.0497.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
pembrolizumab; immunotherapy; temozolomide; durvalumab; brain tumor; cell migration; metastasis; glioblastoma; PD-1; PD-L1
Online: 7 December 2023 (16:57:26 CET)